H

Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo | Predio dos Ambulatorios - Rheumatology Department

Research site
(Unclaimed)
Location
Avenida Doutor Eneas de Carvalho Aguiar 155 PAMB 4 Andar, São Paulo, São Paulo, Brazil
Site insights

Top conditions

Lymphoma (2 trials)

Follicular Lymphoma (1 trial)

B-Cell Lymphoma (1 trial)

Diffuse Large B-Cell Lymphoma (1 trial)

Preleukemia (1 trial)

Top treatments

Lenalidomide
Azacitidine
R-CHOP
Prednisone
Doxorubicin Hydrochloride
Upadacitinib
Vincristine
Cyclophosphamide

Parent organization

This site is a part of Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

4 of 4
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) (EPCORE DLBCL-2)

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). The purpose of t...

Enrolling
Diffuse Large B-Cell Lymphoma
Drug: Epcoritamab
Drug: Rituximab

Systemic Lupus Erythematosus (SLE) is an immune-mediated disease associated with inflammation of multiple organ systems. This study will assess how s...

Enrolling
Systemic Lupus Erythematosus
Drug: Upadacitinib
Drug: Placebo

Follicular Lymphoma (FL) is the second most common B-cell cancer and the most common type of cancer of lymphocytes. Unfortunately, this disease is in...

Enrolling
Follicular Lymphoma (FL)
Drug: Rituximab
Drug: Lenalidomide

Myelodysplastic Syndrome (MDS) is a group of disorders that gradually affect the ability of a person's bone marrow (semi-liquid tissue present in man...

Active, not recruiting
Myelodysplastic Syndrome (MDS)
Drug: Azacitidine
Drug: Venetoclax

Trial sponsors

AbbVie logo

AbbVie (4 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems